TEBU-BIO ApS: Financial statements 2019
CVR: 10156920
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
TEBU-BIO ApS (CVR 10156920) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 661,381 and a net result of DKK 85,847 compared with DKK 128,053 the year before. That is an increase of 1% compared with the year before. Equity in the 2019 report amounted to DKK 210,911. The solvency ratio was 36.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 661,381
- Profit/Loss
- DKK 85,847
- Equity
- DKK 210,911
- Total Assets
- DKK 576,780
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 661 t. | 86 t. | 211 t. | 1 |
| 2018 | - | 655 t. | 128 t. | 280 t. | 1 |
| 2017 | - | 525 t. | 9 t. | 152 t. | 1 |
| 2016 | - | 862 t. | 247 t. | 383 t. | 1 |
| 2015 | - | 979 t. | 375 t. | 511 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
TEBU-BIO ApS has published its annual report for 2018. Gross profit came to DKK 654,861, and the net result was DKK 128,053.
About TEBU-BIO ApS
TEBU-BIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Donald van Dijk. The company is owned by Tebu bio S.A.. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,064,139 and a net result of DKK -414,038 compared with DKK -60,754 the year before. Equity in the 2025 report amounted to DKK -12,652.